Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cardiac Health Institute (CHI) is a premier cardiology practice and clinical research organization based in Sydney, Australia. Founded by Professor Hosen Kiat, the institute integrates high-level clinical care with cutting-edge medical research, particularly in the fields of cardiac imaging and pharmacotherapy. CHI serves as a key site for global Phase 2 and Phase 3 clinical trials, partnering with international pharmaceutical companies to evaluate novel treatments for cardiovascular diseases. Its facilities offer advanced diagnostic services, including PET and CT scanning, alongside specialized clinics for hypertension and lipid management. The institute is dedicated to improving patient outcomes through both direct clinical intervention and the advancement of evidence-based cardiovascular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiac Health Institute.